1
|
Rubenstein BL, Chinkhumba J, Chilima E, Kwizombe C, Malpass A, Cash S, Wright K, Troell P, Nsona H, Kachale F, Ali D, Kaunda E, Lankhulani S, Kayange M, Mathanga DP, Munthali J, Gutman JR. A cluster randomized trial of delivery of intermittent preventive treatment of malaria in pregnancy at the community level in Malawi. Malar J 2022; 21:195. [PMID: 35729612 PMCID: PMC9210049 DOI: 10.1186/s12936-022-04216-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/15/2021] [Accepted: 06/11/2022] [Indexed: 11/10/2022] Open
Abstract
Background Malaria in pregnancy doubles the risk of low birthweight; up to 11% of all neonatal deaths in sub-Saharan Africa are associated with malaria in pregnancy. To prevent these and other adverse health consequences, the World Health Organization recommends administering intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine–pyrimethamine for all pregnant women at each antenatal care (ANC) visit, starting as early as possible in the second trimester. The target is for countries to administer a minimum of three doses (IPTp3+) to at least 85% of pregnant women. Methods A cluster randomized, controlled trial was conducted to assess the effect of delivery of IPTp by community health workers on the coverage of IPTp3 + and ANC visits in Malawi. Community delivery of IPTp was implemented within two districts in Malawi over a 21-month period, from November 2018 to July 2020. In control sites, IPTp was delivered at health facilities. Representative samples of women who delivered in the prior 12 months were surveyed at baseline (n = 370, December 2017) and endline (n = 687, August 2020). A difference in differences analysis was conducted to assess the change in coverage of IPTp and ANC over time, accounting for clustering at the health facility level. Results Overall IPTp coverage increased over the study period. At baseline, women received a mean of 2.3 IPTp doses (range 0–5 doses) across both arms, and at endline, women received a mean of 2.8 doses (range 0–9 doses). Despite overall increases, the change in IPTp3 + coverage was not significantly different between intervention and control groups (6.9%, 95% CI: -5.9%, 19.6%). ANC4 + coverage increased significantly in the intervention group compared with the control group, with a difference-in-differences of 25.3% points (95% CI: 1.3%, 49.3%). Conclusions In order to reduce the burden of malaria in pregnancy, new strategies are needed to improve uptake of effective interventions such as IPTp. While community health workers’ delivery of IPTp did not increase uptake in this study, they may be effective in other settings or circumstances. Further research can help identify the health systems characteristics that are conducive to community delivery of IPTp and the operational requirements for effective implementation. Trial registration: ClinicalTrials.gov Identifier: NCT03376217. Registered December 6, 2017, https://clinicaltrials.gov/ct2/show/NCT03376217.
Collapse
Affiliation(s)
- Beth L Rubenstein
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), 1600 Clifton Rd, Atlanta, GA, 30329, USA
| | - Jobiba Chinkhumba
- University of Malawi College of Medicine, Malaria Alert Centre, Blantyre, Malawi
| | - Ethel Chilima
- Management Sciences for Health (MSH), Lilongwe, Malawi
| | - Collins Kwizombe
- U.S. President's Malaria Initiative, United States Agency for International Development (USAID), Lilongwe, Malawi
| | - Ashley Malpass
- U.S. President's Malaria Initiative, United States Agency for International Development (USAID), Washington, D.C, USA
| | - Shelby Cash
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, U.S. President's Malaria Initiative, Centers for Disease Control and Prevention, Atlanta, GA, USA
| | | | - Peter Troell
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, U.S. President's Malaria Initiative, Centers for Disease Control and Prevention, Lilongwe, Malawi
| | | | | | | | | | | | | | - Don P Mathanga
- University of Malawi College of Medicine, Malaria Alert Centre, Blantyre, Malawi
| | - John Munthali
- Management Sciences for Health (MSH), Lilongwe, Malawi
| | - Julie R Gutman
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), 1600 Clifton Rd, Atlanta, GA, 30329, USA.
| |
Collapse
|
3
|
Abstract
A retrospective audit of all cases of bone and joint TB registered in theTB office at Queen Elizabeth Central Hospital (QECH) from 1986 to 2002 was conducted with the aim of quantifying the proportion of bone and joint TB. The study period coincides with that of the HIV pandemic. A total of 37,075 cases were recorded with 599 (1.6%) involving the skeletal system; of the skeletal TB, 90% involved the spine. The absolute numbers of skeletal TB have remained relatively constant, fluctuating between 14 and 58 per year, while the total number of cases has progressively increased from 657 in 1986 to 3469 in 2002.
Collapse
Affiliation(s)
- N C Mkandawire
- Department of Orthopaedics, Queen Elizabeth Central Hospital, Blantyre, Malawi.
| | | |
Collapse
|